Nocopi Technologies Inc

Nocopi Technologies Inc has a capital structure with no long-term debt and a debt-to-equity ratio of 0.0, indicating a fully equity-funded operation. The company's liquidity position is strong, with a current ratio of 5.01, suggesting it has sufficient short-term assets to cover its liabilities. However, the company reported negative operating income of $1,159,600 and net income of $1,028,200, indicating a significant loss in the most recent period. The return on equity (ROE) is -9.06%, and the return on assets (ROA) is -7.39%, both of which are well below the industry median for specialty chemicals, which typically shows positive returns.

The company's profitability is a concern, as it is operating at a loss despite generating $398.3 million in revenue. The gross profit of $165.6 million suggests that the company is able to maintain a reasonable margin on its products, but the operating and net losses indicate that other costs, such as R&D or SG&A, are significantly impacting the bottom line. The operating cash flow is positive at $264,200, but the free cash flow is negative at $1,022,000, indicating that the company is not generating enough cash to cover its capital expenditures and other operational needs.

Nocopi Technologies Inc's revenue is concentrated in a single business segment, as no segmental breakdown is provided in the available data. The company's geographic exposure is not disclosed in the financial snapshot, but the lack of segmental or geographic diversification could pose a concentration risk if demand in its primary market declines. The company's capital expenditures are minimal at $8,000, suggesting a low level of investment in new projects or expansion.

The company's growth trajectory is uncertain, as the most recent financial data shows a significant decline in profitability. The operating and net losses suggest that the company is not currently generating sustainable earnings, and there is no indication of a turnaround in the near term. The company's free cash flow is negative, which could limit its ability to invest in growth opportunities or return value to shareholders. The lack of long-term debt and the strong liquidity position provide some flexibility, but the company will need to address its profitability issues to sustain long-term growth.

The risk assessment indicates that the company has low liquidity and dilution risk, with no immediate filing-based flags detected. However, the company's negative net income and free cash flow suggest that it may need to raise additional capital in the future, which could lead to dilution for existing shareholders. The valuation adjustments applied in the custom valuations do not indicate any material changes to the company's financial position, but the negative returns on equity and assets suggest that the company is underperforming relative to its peers.

Recent events, such as the company's reported earnings, indicate that the company is not meeting profitability expectations. The last actual EPS was reported at $0.10, which is significantly lower than what might be expected for a company with $398.3 million in revenue. The lack of detailed information on recent filings or transcripts makes it difficult to assess the company's strategic direction or operational performance in more detail.

The company maintains a zero long-term debt position, providing a strong balance sheet with no interest obligations.

A current ratio of 45.02 indicates exceptional short-term liquidity, significantly exceeding typical industry standards for solvency.

Net income improved by 94.2% year-over-year, demonstrating a significant recovery in profitability from the prior period.

Free cash flow surged 94.4% year-over-year, highlighting a substantial improvement in cash generation capabilities.

Dilution and liquidity risks are assessed as low, suggesting stable capital structure and adequate market trading conditions.

The company remains unprofitable with a negative net margin of -2.58%, failing to generate earnings on sales.

Operating and net margins rank in the bottom quartile of the diversified specialty chemicals cohort, indicating poor efficiency.

High credit risk is flagged, suggesting potential difficulties in meeting financial obligations or securing favorable financing terms.